We are live on ! Find out more
Corient Private Wealth

Corient Private Wealth Portfolio holdings

AUM $69.9B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+22.19%
3 Year Est. Return
+69.97%
5 Year Est. Return
10 Year Est. Return
AUM
$43.3B
AUM Growth
+$6.11B
Cap. Flow
+$3.58B
Cap. Flow %
8.25%
Top 10 Hldgs %
20.19%
Holding
2,215
New
212
Increased
899
Reduced
831
Closed
142

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$123M
2
AAPL icon
Apple
AAPL
+$110M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$105M
4
MSFT icon
Microsoft
MSFT
+$99.8M
5
MRK icon
Merck
MRK
+$91.1M

Sector Composition

Rank Sector Weight
1 Technology 19.56%
2 Healthcare 10.92%
3 Financials 9.52%
4 Industrials 7.45%
5 Consumer Discretionary 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCT
2026
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$42.8K ﹤0.01%
6,210
-1,313
-17% -$8.66K
AMRN
2027
Amarin Corp
AMRN
$285M
$40.1K ﹤0.01%
1,683
-10
-0.6% -$257
SRTA
2028
Strata Critical Medical Inc
SRTA
$440M
$39.4K ﹤0.01%
10,000
GAME icon
2029
GameSquare
GAME
$39.7M
$38.1K ﹤0.01%
+12,656
New +$52.7K
MAGN
2030
Magnera Corp
MAGN
$484M
$37.4K ﹤0.01%
953
-159
-14% -$7.21K
DHC
2031
Diversified Healthcare Trust
DHC
$2.27B
$37.2K ﹤0.01%
+16,520
New +$23.7K
PSIL icon
2032
AdvisorShares Psychedelics ETF
PSIL
$45.8M
$37.1K ﹤0.01%
2,000
WRAP icon
2033
Wrap Technologies
WRAP
$97.5M
$36.5K ﹤0.01%
25,000
DTIL icon
2034
Precision BioSciences
DTIL
$188M
$36.2K ﹤0.01%
2,291
-14
-0.6% -$320
OTLK icon
2035
Outlook Therapeutics
OTLK
$258M
$34.8K ﹤0.01%
1,000
-1,450
-59% -$39.5K
PRTK
2036
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$34.4K ﹤0.01%
15,550
NUVB icon
2037
Nuvation Bio
NUVB
$2.24B
$29.6K ﹤0.01%
+16,420
New +$27.9K
AMRS
2038
DELISTED
Amyris Inc.
AMRS
$26.6K ﹤0.01%
25,786
-3,450
-12% -$3.21K
LLAP
2039
DELISTED
Terran Orbital Corporation
LLAP
$25.2K ﹤0.01%
16,776
-849
-5% -$1.34K
LU icon
2040
Lufax Holding
LU
$1.2B
$25.1K ﹤0.01%
4,387
-17,909
-80% -$118K
UPH
2041
DELISTED
UpHealth, Inc.
UPH
$25K ﹤0.01%
13,298
DNN icon
2042
Denison Mines
DNN
$2.7B
$25K ﹤0.01%
20,000
FAZE
2043
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$24.7K ﹤0.01%
50,055
-14,367
-22% -$7.3K
TIO
2044
DELISTED
Tingo Group, Inc. Common Stock
TIO
$24.2K ﹤0.01%
20,000
TRUE
2045
DELISTED
TrueCar
TRUE
$23.6K ﹤0.01%
+10,433
New +$24.9K
QCLS
2046
Q/C Technologies Inc
QCLS
$25.7M
$22.5K ﹤0.01%
5
SHFS icon
2047
SHF Holdings
SHFS
$1.26M
$21.2K ﹤0.01%
+2,000
New +$20.3K
QBTS icon
2048
D-Wave Quantum
QBTS
$6.13B
$20.9K ﹤0.01%
10,000
RLX icon
2049
RLX Technology
RLX
$2.52B
$19.9K ﹤0.01%
+11,255
New +$25.2K
BCEL
2050
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$19.6K ﹤0.01%
20,000

Similar funds

Corient Private Wealth's Q2 2023 Portfolio in Review

As of Q2 2023, Corient Private Wealth held 2,215 positions worth $43.3B, up 16% from $37.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Corient Private Wealth deployed $3.58B of net new capital in Q2 2023, opening 212 new positions and adding to 899 existing holdings. Its largest new stake was Sunnova Energy: 2,271,507 shares worth $41.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $171M trimmed.

  • Corient Private Wealth's largest Q2 2023 buy was Sunnova Energy: 2,271,507 shares worth $41.6M.
  • Corient Private Wealth added most to Lam Research in Q2 2023, an estimated $123M increase.
  • Corient Private Wealth's biggest Q2 2023 reduction was RTX Corp, cutting an estimated $171M.
  • Corient Private Wealth fully exited SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) in Q2 2023, selling an estimated $13.3M.
  • Corient Private Wealth's ten largest holdings make up 20% of its $43.3B portfolio in Q2 2023.
  • Corient Private Wealth opened 212 new positions and closed 142 in Q2 2023.
  • Corient Private Wealth's portfolio value rose 16% quarter-over-quarter to $43.3B.

Based on Corient Private Wealth's 13F filing for Q2 2023, filed 10 Aug 2023.